In this episode of Beyond Page One, host Mickey interviews Kimberly Chew, a seasoned professional in biotech and law. They discuss Kimberly's journey from bench scientist to legal advisor, her involvement in the Human Genome Project, and her focus on the emerging field of psychedelics and mental health. The conversation delves into regulatory challenges, compliance, ethics, marketing strategies, and the role of AI in drug development. Kimberly shares valuable insights for aspiring entrepreneurs in the rapidly evolving biotech industry.

Takeaways

• Kimberly has had two careers, starting as a bench scientist.

• Her experience in the Human Genome Project emphasized collaboration.

• Psychedelics are changing the mental health landscape.

• Regulatory challenges are significant in the psychedelic space.

• Communication is key in advising clients on compliance.

• Ethics are crucial in healthcare and biotech.

• AI is revolutionizing drug development and discovery.

• Shorter acting psychedelic compounds are gaining interest.

• Collaboration with peers and mentors is vital for success.

• Resilience and perseverance are essential traits for entrepreneurs.

  
  

Chapters

00:00 The Journey from Science to Law

02:52 Collaborative Spirit in Biotech

05:28 Psychedelics and Mental Health

07:52 Navigating Regulatory Challenges

10:56 Ethics in Emerging Markets

13:39 Advancements in Psychedelic Therapies

16:02 The Role of AI in Drug Development

18:40 Advice for Aspiring Professionals

24:29 Conclusion